These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 32442166)

  • 1. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.
    Han WM; Apornpong T; Kerr SJ; Hiransuthikul A; Gatechompol S; Do T; Ruxrungtham K; Avihingsanon A
    AIDS Res Ther; 2018 Sep; 15(1):13. PubMed ID: 30261902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy.
    Karo B; Krause G; Castell S; Kollan C; Hamouda O; Haas W;
    BMC Infect Dis; 2017 Jul; 17(1):517. PubMed ID: 28743248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
    Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
    BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
    Gupta-Wright A; Wood R; Bekker LG; Lawn SD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study.
    Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
    BMC Med; 2015 Apr; 13():70. PubMed ID: 25889688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model.
    Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ
    BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.
    Lawn SD; Myer L; Edwards D; Bekker LG; Wood R
    AIDS; 2009 Aug; 23(13):1717-25. PubMed ID: 19461502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
    Van Rie A; Westreich D; Sanne I
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
    Mussini C; Lorenzini P; Cozzi-Lepri A; Lapadula G; Marchetti G; Nicastri E; Cingolani A; Lichtner M; Antinori A; Gori A; d'Arminio Monforte A;
    Lancet HIV; 2015 Mar; 2(3):e98-106. PubMed ID: 26424550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa.
    Kerkhoff AD; Wood R; Cobelens FG; Gupta-Wright A; Bekker LG; Lawn SD
    BMC Infect Dis; 2014 Dec; 14():3860. PubMed ID: 25528467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.